PBSerum 2025 launch

Introducing Recombinant Enzyme Innovation to Aesthetic Medicine

In 2025, Neu Era proudly launched PBSerum, a professional aesthetic brand developed by Proteos Biotech Laboratories and built on advanced recombinant enzyme technology.

The launch marked an important milestone in bringing a new category of enzyme-based aesthetic solutions to doctors and clinic partners in the region. Unlike conventional aesthetic treatments, PBSerum focuses on targeted tissue remodelling, skin quality improvement, and regenerative support through scientifically developed enzyme formulations.

The event brought together aesthetic doctors, clinic owners, and industry professionals for an exclusive introduction to PBSerum’s technology, treatment potential, and clinical positioning. Through brand presentation, product education, and professional engagement, the launch created strong awareness around the role of recombinant enzymes in modern aesthetic practice.

As part of Neu Era’s curated portfolio, PBSerum reflects our commitment to introducing differentiated, science-led solutions that support doctors in addressing a wider range of patient concerns — from skin texture and tissue quality to fibrosis, scarring, and selected face and body protocols.

The PBSerum 2025 Launch reinforced Neu Era’s role as a strategic partner for premium aesthetic brands, helping bring innovative technologies to market with credibility, education, and strong clinical engagement.